Nuvalent IncNASDAQ:NUVL
- LAST PRICE91.0600
- TODAY'S CHANGE (%)3.3700 (3.8431%)
- Bid / Lots91.1000/ 1
- Ask / Lots145.7600/ 2
- Open / Previous Close87.5500 / 87.6900
- Day Range
- 52 Week Range
- Volume358,451
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NUVL |
|---|---|---|
| 09:32 ET | 2531 | 87.55 |
| 09:39 ET | 2526 | 87.545 |
| 09:42 ET | 6375 | 87.81 |
| 09:44 ET | 1135 | 87.92 |
| 09:46 ET | 2140 | 87.875 |
| 09:48 ET | 3110 | 87.88 |
| 09:50 ET | 12508 | 87.94 |
| 09:51 ET | 1301 | 87.78 |
| 09:53 ET | 1100 | 87.755 |
| 09:55 ET | 700 | 87.755 |
| 09:57 ET | 150 | 87.785 |
| 10:00 ET | 100 | 88 |
| 10:02 ET | 100 | 87.94 |
| 10:04 ET | 330 | 88 |
| 10:06 ET | 100 | 87.82 |
| 10:08 ET | 500 | 87.83 |
| 10:09 ET | 2186 | 88.24 |
| 10:13 ET | 1799 | 88.745 |
| 10:15 ET | 1493 | 88.405 |
| 10:18 ET | 200 | 88.7 |
| 10:20 ET | 300 | 88.475 |
| 10:22 ET | 100 | 88.7 |
| 10:24 ET | 100 | 88.7 |
| 10:26 ET | 1496 | 88.5 |
| 10:27 ET | 1972 | 89.06 |
| 10:29 ET | 200 | 89.01 |
| 10:31 ET | 720 | 89.125 |
| 10:33 ET | 100 | 89.36 |
| 10:36 ET | 200 | 89.45 |
| 10:38 ET | 200 | 89.705 |
| 10:40 ET | 737 | 89.73 |
| 10:42 ET | 1200 | 89.72 |
| 10:45 ET | 1927 | 89.925 |
| 10:47 ET | 100 | 89.945 |
| 10:51 ET | 400 | 90.17 |
| 10:54 ET | 100 | 90.175 |
| 10:56 ET | 300 | 90.31 |
| 10:58 ET | 4517 | 89.515 |
| 11:02 ET | 500 | 89.53 |
| 11:03 ET | 1500 | 89.3 |
| 11:05 ET | 500 | 89.415 |
| 11:09 ET | 702 | 89.5 |
| 11:14 ET | 100 | 89.345 |
| 11:18 ET | 100 | 89.325 |
| 11:20 ET | 300 | 89.55 |
| 11:25 ET | 122 | 89.5 |
| 11:30 ET | 100 | 89.55 |
| 11:32 ET | 4174 | 89.535 |
| 11:34 ET | 400 | 89.55 |
| 11:36 ET | 400 | 89.54 |
| 11:38 ET | 100 | 89.71 |
| 11:39 ET | 100 | 89.555 |
| 11:43 ET | 4900 | 89.9 |
| 11:45 ET | 2226 | 89.61 |
| 11:48 ET | 200 | 89.685 |
| 11:54 ET | 1600 | 90.095 |
| 11:56 ET | 607 | 89.79 |
| 11:59 ET | 100 | 89.81 |
| 12:01 ET | 100 | 89.73 |
| 12:06 ET | 100 | 89.71 |
| 12:14 ET | 2100 | 89.82 |
| 12:15 ET | 1500 | 89.85 |
| 12:17 ET | 3111 | 89.835 |
| 12:19 ET | 200 | 89.86 |
| 12:21 ET | 1000 | 89.72 |
| 12:24 ET | 100 | 89.815 |
| 12:28 ET | 700 | 89.95 |
| 12:30 ET | 1800 | 90.035 |
| 12:33 ET | 1986 | 90.29 |
| 12:42 ET | 100 | 90.165 |
| 12:48 ET | 741 | 89.945 |
| 12:50 ET | 200 | 89.915 |
| 12:51 ET | 600 | 89.97 |
| 12:53 ET | 100 | 90 |
| 12:57 ET | 400 | 89.86 |
| 01:00 ET | 100 | 89.885 |
| 01:02 ET | 200 | 89.93 |
| 01:04 ET | 100 | 89.8 |
| 01:08 ET | 400 | 89.755 |
| 01:11 ET | 278 | 89.87 |
| 01:13 ET | 300 | 89.98 |
| 01:18 ET | 400 | 90.06 |
| 01:20 ET | 714 | 89.89 |
| 01:22 ET | 600 | 89.99 |
| 01:26 ET | 300 | 89.97 |
| 01:27 ET | 100 | 90.13 |
| 01:29 ET | 100 | 89.98 |
| 01:36 ET | 100 | 89.96 |
| 01:38 ET | 200 | 89.99 |
| 01:40 ET | 6550 | 89.98 |
| 01:42 ET | 1100 | 90.21 |
| 01:44 ET | 1300 | 90 |
| 01:45 ET | 400 | 90 |
| 01:47 ET | 300 | 90 |
| 01:49 ET | 230 | 90.12 |
| 01:51 ET | 1220 | 90.075 |
| 01:54 ET | 1146 | 90.37 |
| 01:56 ET | 102 | 90.56 |
| 01:58 ET | 600 | 90.58 |
| 02:00 ET | 3600 | 90.4401 |
| 02:02 ET | 3665 | 90.41 |
| 02:03 ET | 2088 | 90.41 |
| 02:05 ET | 100 | 90.425 |
| 02:07 ET | 200 | 90.425 |
| 02:09 ET | 1100 | 90.49 |
| 02:12 ET | 200 | 90.68 |
| 02:14 ET | 100 | 90.615 |
| 02:16 ET | 100 | 90.515 |
| 02:30 ET | 400 | 90.455 |
| 02:32 ET | 300 | 90.3 |
| 02:36 ET | 487 | 90.4475 |
| 02:38 ET | 100 | 90.455 |
| 02:41 ET | 400 | 90.59 |
| 02:43 ET | 300 | 90.65 |
| 02:48 ET | 3553 | 90.31 |
| 02:50 ET | 200 | 90.32 |
| 02:52 ET | 525 | 90.11 |
| 02:54 ET | 100 | 90.125 |
| 02:57 ET | 100 | 90.145 |
| 02:59 ET | 200 | 90.17 |
| 03:01 ET | 2061 | 90.3081 |
| 03:03 ET | 1210 | 89.99 |
| 03:06 ET | 100 | 89.925 |
| 03:08 ET | 200 | 90.04 |
| 03:10 ET | 300 | 89.995 |
| 03:12 ET | 700 | 90.13 |
| 03:14 ET | 500 | 90.2 |
| 03:19 ET | 753 | 90.295 |
| 03:21 ET | 200 | 90.16 |
| 03:26 ET | 100 | 90.25 |
| 03:28 ET | 1964 | 90.41 |
| 03:30 ET | 1900 | 90.365 |
| 03:32 ET | 1713 | 90.44 |
| 03:33 ET | 821 | 90.44 |
| 03:35 ET | 1400 | 90.38 |
| 03:37 ET | 800 | 90.51 |
| 03:39 ET | 3849 | 90.55 |
| 03:42 ET | 600 | 90.495 |
| 03:44 ET | 500 | 90.495 |
| 03:46 ET | 942 | 90.805 |
| 03:48 ET | 4700 | 90.86 |
| 03:50 ET | 1000 | 90.83 |
| 03:51 ET | 7405 | 90.6625 |
| 03:53 ET | 6064 | 90.82 |
| 03:55 ET | 6529 | 90.895 |
| 03:57 ET | 7972 | 91.09 |
| 04:00 ET | 57334 | 91.06 |
Nov 13, 2024
DJ Nuvalent Is Maintained at Outperform by BMO Capital, from 8:14AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:14AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Press Release: Nuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results, from 6:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
6:30AM ET on Tuesday Nov 12, 2024 by Dow JonesNuvalent Highlights Corporate and Pipeline Achievements, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2024 Financial Results, from 6:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
6:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 24, 2024
DJ Nuvalent Initiated at Neutral by UBS, from 8:05AM ET on Thursday Oct 24, 2024 by Dow Jones
8:05AM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 23, 2024
DJ Nuvalent Down Over 8%, on Pace for Largest Percent Decrease in Over a Year -- Data Talk, from 2:50PM ET on Wednesday Oct 23, 2024 by Dow Jones
2:50PM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nuvalent Inc | 5.9B | -26.2x | --- |
Viking Therapeutics Inc | 5.7B | -55.0x | --- |
Cytokinetics Inc | 6.0B | -9.5x | --- |
Madrigal Pharmaceuticals Inc | 6.9B | -12.5x | --- |
Avidity Biosciences Inc | 5.2B | -14.9x | --- |
Crinetics Pharmaceuticals Inc | 4.9B | -14.8x | --- |
Company Information
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, NVL-520, is being developed for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, NVL-655, is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC. LC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor.
Contact Information
- Headquarters
- One Broadway, 14th FloorCAMBRIDGE, MA, United States 02142
- Phone
- 857-357-7000
- Fax
- 302-655-5049
Executives
- Non-Executive Independent Chairman of the Board
- Anna Protopapas
- President, Chief Executive Officer, Director
- James Porter
- Chief Financial Officer, Treasurer
- Alexandra Balcom
- Chief Development Officer
- Darlene Noci
- Chief Medical Officer
- Christopher Turner
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 65.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.31 |
EPS | $-3.48 |
Book Value | $10.94 |
P/E Ratio | -26.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
